Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers
NCT06703905 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270
Last updated 2024-11-25
Summary
The goal of this clinical trial is to learn if traditional pancreaticoduodenectomy (PD) combined with TRIANGLE (extended PD surgery) can increase disease-free survival (DFS) in patients with pancreatic head cancers compared to traditional minimally invasive PD. The main questions it aims to answer are:
* Does extended PD surgery increase disease-free survival (DFS)?
* Does extended PD surgery could improve postoperative and long-term quality of life for patients? Researchers will compare extended PD surgery to traditional PD surgery to see if extended PD surgery could extend the survival time of patients.
Participants will:
* Accept traditional minimally invasive PD surgery or minimally invasive PD combined with TRIANGLE surgery.
* Visit the clinic once every 3 months for checkups and tests.
* Keep a diary of their symptoms.
Conditions
- Pancreatic Cancer Resectable
Interventions
- PROCEDURE
-
Expanded pancreaticoduodenectomy surgery
Traditional minimally invasive pancreaticoduodenectomy combined with the TRIANGLE procedure
- PROCEDURE
-
Pancreaticoduodenectomy
Traditional minimally invasive pancreaticoduodenectomy
Sponsors & Collaborators
-
First Affiliated Hospital Xi'an Jiaotong University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-31
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
More Related Trials
-
Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.
NCT05723978 ·Status: COMPLETED
-
Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer
NCT01569282 ·Status: WITHDRAWN ·Phase: NA
-
Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy
NCT03398291 ·Status: UNKNOWN ·Phase: PHASE3
-
Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer
NCT06677762 ·Status: NOT_YET_RECRUITING
-
Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma
NCT02928081 ·Status: UNKNOWN ·Phase: NA
-
Extended Retroperitoneal Lymphadenectomy and Nerve Plexus Clearance Versus Standard Lymphadenectomy in Pancreaticoduodenectomy
NCT03081351 ·Status: UNKNOWN ·Phase: NA
-
The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer
NCT06873178 ·Status: ACTIVE_NOT_RECRUITING
-
Multimodal Therapy Impact on Pancreatic Cancer Survival
NCT06938906 ·Status: ACTIVE_NOT_RECRUITING
-
Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes
NCT07272109 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?
NCT06921252 ·Status: COMPLETED
-
Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery
NCT02930902 ·Status: COMPLETED ·Phase: PHASE1
-
Pancreatic Cancer and Diabetes Mellitus
NCT06585072 ·Status: RECRUITING
-
Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors
NCT04400357 ·Status: COMPLETED ·Phase: NA
-
Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula
NCT05843877 ·Status: RECRUITING ·Phase: PHASE3
-
Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study
NCT04737551 ·Status: UNKNOWN
-
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
NCT02707315 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.
NCT06099119 ·Status: RECRUITING ·Phase: PHASE4
-
Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer
NCT05611359 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
NCT06389760 ·Status: RECRUITING ·Phase: PHASE2
-
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
NCT06980792 ·Status: COMPLETED
-
Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis
NCT06307080 ·Status: RECRUITING ·Phase: NA
-
An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
NCT04310553 ·Status: UNKNOWN ·Phase: NA
-
Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer
NCT03983057 ·Status: COMPLETED ·Phase: PHASE2
-
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.
NCT04835064 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
NCT00020345 ·Status: COMPLETED ·Phase: PHASE2